Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia.

M Aviram, J G Brook

    Israel Journal of Medical Sciences
    |November 1, 1985
    PubMed
    Summary

    Patients with Type V hyperlipoproteinemia exhibit abnormal plasma lipoproteins, leading to reduced platelet aggregation and serotonin release. These findings suggest a link between altered lipoprotein patterns and impaired platelet function in this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pulmonary involvement in Niemann-Pick C type 1.

    European journal of pediatrics·2018
    Same author

    Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And Implementation.

    Scientific reports·2016
    Same author

    Reduced glutathione increases quercetin stimulatory effects on HDL- or apoA1-mediated cholesterol efflux from J774A.1 macrophages.

    Free radical research·2014
    Same author

    Monocyte-macrophage membrane possesses free radicals scavenging activity: stimulation by polyphenols or by paraoxonase 1 (PON1).

    Free radical research·2013
    Same author

    Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease.

    International journal of hepatology·2012
    Same author

    Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.

    The European respiratory journal·2011

    Area of Science:

    • Biochemistry
    • Hematology
    • Metabolic Disorders

    Background:

    • Type V hyperlipoproteinemia is characterized by elevated plasma triglycerides and cholesterol.
    • Platelet dysfunction has been anecdotally reported in hyperlipoproteinemic states.

    Purpose of the Study:

    • To investigate plasma lipid and lipoprotein profiles in patients with primary Type V hyperlipoproteinemia.
    • To assess platelet aggregation and [14C]serotonin release in these patients.
    • To determine the impact of patient-derived lipoproteins on normal platelet function.

    Main Methods:

    • Analysis of plasma very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) lipid and protein content.
    • Quantification of apolipoproteins E and C-III in VLDL and HDL.

    Related Experiment Videos

  • Measurement of platelet aggregation and [14C]serotonin release.
  • In vitro incubation of patient and control lipoproteins with normal platelets.
  • Main Results:

    • Patients showed significantly elevated VLDL cholesterol, triglycerides, and protein, altering cholesterol:protein and TG:protein ratios.
    • LDL and HDL exhibited a threefold increase in TG:protein ratio.
    • Patient VLDL had increased apo E and sialyzed apo C-III (C-III2), with decreased apo C-III0.
    • Patient HDL showed lower sialyzed apo C-IIIs.
    • Platelet aggregation and serotonin release were decreased in patients and further impaired when exposed to patient lipoproteins.

    Conclusions:

    • Primary Type V hyperlipoproteinemia is associated with distinct plasma lipoprotein abnormalities.
    • These lipoprotein alterations may be responsible for the observed depressed platelet aggregation and serotonin release.
    • The findings suggest a direct role for abnormal lipoproteins in platelet dysfunction in Type V hyperlipoproteinemia.